Frost & Sullivan Report: MIC Among Companies Expected to See Fastest Growth During and After Pandemic in Healthcare’s Virtual Critical Care Space

Research firm predicts future growth in market to be accelerated by affordable, easy-to-deploy, scalable solutions like Sickbay

HOUSTON--()--Frost & Sullivan, a research and consulting firm that helps clients accelerate growth, named MIC as one of the companies expected to see the fastest growth during and post-pandemic in the virtual care market. The prediction was made in a recent Frost & Sullivan report, Increasing Demand for Value-based Care and Acute Shortage of ICU Staff to Drive Growth of the US & EU-5 Virtual Critical Care Solutions Market, 2025, which examined virtual critical care options to address staffing shortages, reduce mortality and length of stay, increase ICU bed capacity and reduce the number of patient transfers for hospitals.

“This is a critical time for the healthcare industry to address important roadblocks to the growth of critical care,” noted Emma Fauss, co-founder and CEO of MIC, a Houston-based technology company challenging the model of clinical innovation by accelerating speed to market and disrupting traditionally high costs through software. “But most importantly, this is a turning point for hospitals to enable virtual care across vendors and all inpatient settings, simplify IT architecture and gain access to information that has been siloed and locked down for years. It is a time where care can be personalized through patient-centered algorithms that leverage machine learning and AI. We need to empower care teams to save more lives through data-driven medicine.”

In the report, Frost & Sullivan noted Sickbay, MIC’s FDA-cleared platform, as an example of a “Tier II” technology, noting that this flexible clinical surveillance software solution platform leverages the existing hospital infrastructure, thus allowing for easy scale up. It also recognized the platform for specialized mobile analytics and visualization. Frost & Sullivan predicted that “affordable and quick-to-deploy software-based solutions from vendor-agnostic Tier II and Tier III companies are expected to see the fastest growth both during and after the pandemic.”

In addition to improving clinical outcomes, in-demand solutions like Sickbay incorporate customizable and flexible components, the report details. Features associated with Tier II solutions for virtual critical care—inherent to MIC’s Sickbay—included attributes such as:

  • Easy to deploy and scale, with deployment in a matter of weeks upon existing infrastructure, saving both time and money
  • Customizable and flexible for protocols, risk scores and view, allowing clinicians to customize per patient group and set clinical conditions for better predictive risk assessments, and ability to view data from anywhere
  • Enabling remote notification and alerts, freeing up already-stretched staff and prioritizing care for patients at higher risk

Restraints to the growth of other virtual care solutions outside of Tier II included barriers of organizational changes needed to address tele-ICU implementation; high start-up costs that can be up to $100,000 per bed for centralized virtual ICU care; and lack of data integration and interoperability, resulting in incomplete insights being offered to clinicians. Tier II solutions like MIC's Sickbay were found to offer multiple adoption advantages.

“We know from our work in healthcare facilities across the country that clinicians are frustrated by the lack of patient data – how hard, expensive and disparate it is. We also know that hospitals don’t want to shoulder high costs for outdated hardware, and that healthcare systems are hamstrung by a web of single point ‘solutions’ that do little except cause both complications to their IT infrastructure and significant time and cost to maintain,” noted Fauss. “Through software-based solutions like Sickbay, we are solving for this, even for hospitals that already have other solutions in place. We are elated that Frost & Sullivan studied this complex issue and made excellent recommendations for how healthcare can move forward into a new standard of care that is truly centered on patients.”

For further information on this analysis and to access a preview of the report, Increasing Demand for Value-based Care and Acute Shortage of ICU Staff to Drive Growth of the US & EU-5 Virtual Critical Care Solutions Market, 2025, please visit: http://frost.ly/59y.

ABOUT MIC

Medical Informatics Corp (MIC) is empowering a new standard of healthcare by accessing, synthesizing, and delivering patient-specific data to clinicians to help them save more lives. Through the company’s FDA-cleared Sickbay™ virtual care and analytics platform, MIC provides a singular, interconnected architecture that helps hospitals solve clinical needs to reduce costs, increase revenue, and improve operational efficiencies. MIC’s flexible, software-based solution enables rapid scaling of vendor-neutral remote patient monitoring across any inpatient setting and the ability to accelerate the development and deployment of patient-centered AI at scale. Fueled by innovative engineers, mathematicians, clinicians, researchers, and entrepreneurs whose work with clinicians at the bedside led to groundbreaking discoveries, MIC is based in Houston, Texas, and works alongside hospitals and healthcare systems across the country to create a new standard of care driven by unprecedented access to patient data. More information is available at michealthcare.com.

Contacts

Karen Jimenez
Director of Digital Marketing
Medical Informatics Corp.
Phone: 832-303-3113

Release Summary

Frost & Sullivan names Medical Informatics Corp. as one of the companies expected to see the fastest growth in the virtual care market.

Contacts

Karen Jimenez
Director of Digital Marketing
Medical Informatics Corp.
Phone: 832-303-3113